Company intelligence / Profile preview

PorMedTec

Ownership: Private
Development stage: Preclinical

Overview

Successfully produced genetically engineered pigs with organs suitable for human transplantation. In November 2024, completed first pig kidney transplant into a monkey in Japan, with the monkey showing good condition and proper kidney function.

Therapeutic areas: OtherNephrology
Modalities: XenotransplantationGenetically engineered organs and tissues
Industry: Non-Drug Biotech

Partnerships

eGenesis (US biotech company)

Beyond the preview

Go deeper on PorMedTec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PorMedTec.

Explore the full profile